WINT•benzinga•
Windtree Therapeutics Plans Interim Analysis Results For Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study For July 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 22, 2025 by benzinga